Vyome (HIND) Proxy filing summary

Executive summary

• The annual meeting is scheduled for April 24, 2026, with proposals including director elections, a reduction in authorized common stock, auditor ratification, and an advisory vote on executive compensation.

• The board recommends voting in favor of all proposals and highlights the importance of shareholder participation.

• Forward-looking statements address future financial performance, business operations, and compensation decisions, subject to risks and uncertainties.

Voting matters and shareholder proposals

• Shareholders will vote on electing two Class II directors, reducing authorized common stock from 300,000,000 to 50,000,000 shares, ratifying Kreit & Chiu CPA LLP as auditor, and an advisory say-on-pay vote.

• The board unanimously recommends voting for all proposals.

• Shareholder proposals for the 2027 meeting must be submitted by November 30, 2026, for inclusion in the proxy statement.

Board of directors and corporate governance

• The board consists of six members, with staggered three-year terms and specific designation rights for certain shareholders.

• Committees include audit, compensation, nominating and governance, and an AI committee focused on healthcare AI initiatives.

• Four directors are deemed independent under SEC and Nasdaq rules.

• Directors are encouraged to attend the annual meeting, and non-employee directors receive no compensation for board service.